Eight hundred thirty-nine patients were confirmed with PD-1/PD-L1 inhibitor-related myocarditis, accounting for 15.4% of all cardiac disorders; 0.65% of all irAEs are caused by immune checkpoint inhibitor treatment (Rubio-Infante et al., 2021). This evidence concerns the gene CD274 and myocarditis.